4th Annual Life Sciences Compliance Congress for Specialty Product Manufacturers at 11:15am on Friday, September 14, 2018 in Cambridge, MA.
| PORTSMOUTH, N.H., Sept. 10, 2018 /PRNewswire/ -- Darryl Williams, MediSpend’s senior director analytics, will co-present with Sanofi’s associate director, Masha Chestukhin a discussion surrounding the challenges associated with scaling a global compliance operations at the 4th Annual Life Sciences Compliance Congress for Specialty Product Manufacturers at 11:15am on Friday, September 14, 2018 in Cambridge, MA. The session, “Scale Up Your Compliance Program for Global Operations” will explore the tools for a scalable compliance program that can meet the challenges that come with the business’s expanding aspirations and practices. Additionally, the presenters will discuss assessing the risks that come with recruiting international research sites and studies. “Compliance programs are often developed as reactionary measures,” said Williams. “As a specialty pharmaceutical company begins global expansion, we take action by gaining insights from multiple sources.” CBI’s 4th Annual Life Sciences Compliance Congress for Specialty Product Manufacturers serves as the life sciences industry’s only conference catered to the unique compliance challenges for specialty bio/pharmaceutical companies, pre- and post-commercialization. The event will be held at the Royal Sonesta Boston in Cambridge, MA About MediSpend Media Contact: SOURCE MediSpend |
